OpenVSafe by OpenVAERS
Search V-safe

KBR-31717-04829

3 vaccinations 5 coded responses 15 check-ins 5 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
968 / HI
Registered
2020-12-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-23
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-25
    Registered in v-safe
  3. 2020-12-26
    Survey response — days 1–6 daily, dose 1
    MedDRA: Upper-airway cough syndrome — Feeling: Fair · Fatigue or tiredness
    Free text: Post-nasal drip
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2020-12-29
    Survey response — days 1–6 daily, dose 1
    MedDRA: Rhinorrhoea — Feeling: Fair
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2020-12-30
    Survey response — day 7, dose 1
    MedDRA: Rhinorrhoea — Feeling: Fair
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-01-12
    Dose 2 — Pfizer-BioNTech
  9. 2021-01-21
    Survey response — day 7, dose 2
    MedDRA: Myalgia — Feeling: Good
    Free text: Muscle aches the first night after getting the shot
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-01-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-02-02
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-02-09
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-02-16
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-23
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-04-13
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-07-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-11-02
    Dose 3 — Pfizer-BioNTech
  18. 2022-01-14
    Survey response — 12 months, dose 2
    MedDRA: Fatigue, Nasopharyngitis, Pregnancy, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school
    Free text: Congestion, fatigue, headache (probably a cold - tested negative twice for COVID). Still pregnant
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-11-02
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Pfizer-BioNTech
22021-01-12Pfizer-BioNTech
32021-11-02Pfizer-BioNTech No

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-26

Systemic reaction (other): Post-nasal drip

2020-12-29

Systemic reaction (other): Runny nose

Release 1 — day 7, dose 1

2020-12-30

Systemic reaction (other): Runny nose

Release 2 — day 7, dose 2

2021-01-21

Systemic reaction (other): Muscle aches the first night after getting the shot

Release 10 — 12 months, dose 2

2022-01-14

Symptoms: Congestion, fatigue, headache (probably a cold - tested negative twice for COVID). Still pregnant

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDFatigue · · ✓
SDNasopharyngitis · · ✓
SDPregnancy · · ✓
SDRespiratory tract congestion · · ✓
SDSARS-CoV-2 test negative · · ✓
SROMyalgia ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓
SROUpper-airway cough syndrome ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release